Projected 2018 revenue for top 10 drugs approved U.S. 2013

Projected 2018 revenue for top 10 drugs approved in the U.S. in 2013 (in million U.S. dollars)

by Statista Research Department, last edited Mar 11, 2014
Projected 2018 revenue for top 10 drugs approved U.S. 2013 This statistic displays the projected 2018 revenue for top 10 drugs approved in the U.S. in 2013. Tivicay, approved on August 12, 2013, and developed by GlaxoSmithKline, is estimated to generate 2.13 billion U.S. dollars in annual revenue in 2018. Pharmaceutical and biotechnology companies experienced widespread growth worldwide with the United States garnering the largest growth.
Show more

Projected 2018 revenue for top 10 drugs approved in the U.S. in 2013 (in million U.S. dollars)

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Pharmaceutical industry in Norway "
  • Overview
The most important statistics
  • Production and trade
  • Pharmaceutical turnover
  • R&D, patents and new products
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.